Haoyuan Ding

420 total citations
33 papers, 202 citations indexed

About

Haoyuan Ding is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Cancer Research. According to data from OpenAlex, Haoyuan Ding has authored 33 papers receiving a total of 202 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Cancer Research. Recurrent topics in Haoyuan Ding's work include Peptidase Inhibition and Analysis (10 papers), Protease and Inhibitor Mechanisms (8 papers) and Radiopharmaceutical Chemistry and Applications (6 papers). Haoyuan Ding is often cited by papers focused on Peptidase Inhibition and Analysis (10 papers), Protease and Inhibitor Mechanisms (8 papers) and Radiopharmaceutical Chemistry and Applications (6 papers). Haoyuan Ding collaborates with scholars based in China, Germany and South Korea. Haoyuan Ding's co-authors include Yue Chen, Liang Cai, Tingting Xu, Yan Zhao, Zhijun Zhou, Shuai Yuan, Shumao Zhang, Zhanwen Huang, Qi Zhang and Peng Gao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Frontiers in Immunology and Aquaculture.

In The Last Decade

Haoyuan Ding

25 papers receiving 198 citations

Peers

Haoyuan Ding
Comparison fields: 5 of 68
  • Oncology 101
  • Surgery 69
  • Cancer Research 66
  • Mechanical Engineering 26
  • Molecular Biology 22
Replace Jiaqi Ren with:
Jiaqi Ren China
Yoichi Kawano Japan
Yangyang Cai China
Jianwei Lin China
Jingwen Zou China
Qizhen Huang China
Ke Lian China
Bin Shen China
Jiaqi Ren China View profile →
Citations per field, relative to Haoyuan Ding
Haoyuan Ding · 1×
Citations per year, relative to Haoyuan Ding
Haoyuan Ding · 1×

Countries citing papers authored by Haoyuan Ding

Since Specialization
Citations

This map shows the geographic impact of Haoyuan Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haoyuan Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haoyuan Ding more than expected).

Fields of papers citing papers by Haoyuan Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haoyuan Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haoyuan Ding. The network helps show where Haoyuan Ding may publish in the future.

Co-authorship network of co-authors of Haoyuan Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Haoyuan Ding. A scholar is included among the top collaborators of Haoyuan Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haoyuan Ding. Haoyuan Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 1
3 0
4 0
5 0
6 14
7 3
8 0
9 7
10 0
11 2
12 3
13 2
14 10
15 27
16 8
17 2
18 9
19 52
20 21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026